"Questioning the Risk Profile of Selegiline Hydrochloride" Poster exhibit presented by Dr.
Emory at Institute on Psychiatric Services Conference, San Francisco.
May 15-18, 2011
“Questioning the Risk Profile of Selegiline Hydrochloride” Poster exhibit presented by Dr.
Emory at American Psychiatric Association Conference, Honolulu.
Dr. Emory’s innovative neuropsychiatric EEG research has identified unseen brain variations
in persons who suffer with mental disorders, substance dependence and developmental and learning
disorders. Such physical variations are generally not seen with visual inspection of the EEG;
as a result, they are not recognized in current medical, psychiatric and psychological assessments.
Dr. Emory is the world’s most experienced physician in this emerging field that combines neurology,
neuropsychiatry and clinical medicine.
The above pre-treatment EEGs are from anorexic patients after nutritional restoration.
Each was classified as anorexic, but you can see their brainwave activity was different.
Dr. Emory used each patient’s EEG to customize their effective medical regimen.
Traditional psychiatry treats anorexic behaviors in a standard way; however, these EEGs
show why symptoms and behaviors are inadequate for prescribing medication.
PART TWO: IMPROVE VARIANT BRAIN ACTIVITY CAUSING A PERSON’S DISTRESS. HOW IT WORKS:
Dr. Emory’s method is patient centered and includes any emotional, mental and
physical concerns that relate to a person’s distress.
Dr. Emory’s clinical procedure collects the usual subjective information about
each patient, but also adds objective data.
Step I: Clinical Procedures:
Conduct a comprehensive medical history
Relevant physical examination and monitoring of any abnormal medical signs and physical findings
Mental status and cognitive assessments
Individualized laboratory testing as indicated
Step II: Technical Procedure:
Obtain a baseline unmedicated EEG and quantitative EEG for analysis.
Identify how a new patient’s brainwaves differ from people the same age who have no symptoms.
Using Dr. Emory’s extensive brainwave database, identify medications that are known to improve the
brain activity of patients with similar EEG data.
Step III: Medical Treatment Selection
Prescribe medication that is compatible and likely to improve each person’s brain activity.
Monitor each patient’s medical progress.
Side effects mean that the medication is incompatible for the individual’s brain activity
and therefore not tolerated, in such cases Dr. Emory replaces the medication causing them for
one which is better suited.
Step IV: Follow-up
Comprehensively monitor each patient’s clinical progress by reassessing their initial concerns
as well as any abnormal medical signs, physical findings, or problematic mental functions.
Follow-up EEG and quantitative EEG with medication to know how therapy is changing each patient’s
brain activity.